Schedule 13D ownership disclosure
ELEVATION ONCOLOGY INC
Common stock, par value $0.0001 per share · CUSIP: 28623U101
Event date: 2025-04-16
- Filing-level shares
- 5,890,934
- Percent of class
- 9.9%
- BML Investment Partners, L.P.Reported CIK 0001373604
Shares: 5,890,934 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001373604-25-000060
- Form type
- SCHEDULE 13D
- Filer
- BML Investment Partners, L.P.
- CIK
- CIK 1373604
- Filed
- Apr 16, 2025
- Reporting period
- Apr 16, 2025
- Description
- Schedule 13D beneficial ownership